Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric I Benchimol

Showing results (191-200 of 276) with videos related to

Pageof 28
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Pediatric Research|March 31, 2021
Incidence and short-term outcomes of Kawasaki diseaseCal Robinson, Rahul Chanchlani, Anastasia Gayowsky, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
BMC Gastroenterology|May 18, 2022
Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trialNatasha Bollegala, Melanie Barwick, Nancy Fu, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
Inflammatory Bowel Diseases|June 19, 2019
The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel DiseaseLaura E Targownik, Eric I Benchimol, Julia Witt, et al.
Gastrointestinal Endoscopy|October 2, 2018
Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's diseaseNicholas Carman, Diane Tomalty, Peter C Church, et al.
Neurogastroenterology and Motility|November 15, 2022
Impact of antegrade enema initiation on healthcare utilization in pediatric patients: A population-based cohort studyMichelle J Gould, Margaret A Marcon, Geoffrey C Nguyen, et al.
Journal of the Canadian Association of Gastroenterology|September 3, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated VaccinesJennifer L Jones, Frances Tse, Matthew W Carroll, et al.
Pageof 28

Showing results (191-200 of 276) with videos related to

Sort By:
Pageof 28
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Upfront Combination Therapy, Compared With Monotherapy, for Patients Not Previously Treated With a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort StudyLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Journal of Crohn'S & Colitis|July 11, 2020
Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related ComplicationsLaura E Targownik, Eric I Benchimol, Charles N Bernstein, et al.
Pediatric Research|March 31, 2021
Incidence and short-term outcomes of Kawasaki diseaseCal Robinson, Rahul Chanchlani, Anastasia Gayowsky, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBDMatthew W Carroll, M Ellen Kuenzig, David R Mack, et al.
BMC Gastroenterology|May 18, 2022
Multimodal intervention to improve the transition of patients with inflammatory bowel disease from pediatric to adult care: protocol for a randomized controlled trialNatasha Bollegala, Melanie Barwick, Nancy Fu, et al.
Journal of the Canadian Association of Gastroenterology|November 10, 2021
Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Mental Health and Quality of LifeLesley A Graff, Sharyle Fowler, Jennifer L Jones, et al.
Inflammatory Bowel Diseases|June 19, 2019
The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel DiseaseLaura E Targownik, Eric I Benchimol, Julia Witt, et al.
Gastrointestinal Endoscopy|October 2, 2018
Clinical disease activity and endoscopic severity correlate poorly in children newly diagnosed with Crohn's diseaseNicholas Carman, Diane Tomalty, Peter C Church, et al.
Neurogastroenterology and Motility|November 15, 2022
Impact of antegrade enema initiation on healthcare utilization in pediatric patients: A population-based cohort studyMichelle J Gould, Margaret A Marcon, Geoffrey C Nguyen, et al.
Journal of the Canadian Association of Gastroenterology|September 3, 2021
Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 2: Inactivated VaccinesJennifer L Jones, Frances Tse, Matthew W Carroll, et al.
Pageof 28